AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

Request for Emergency Use Authorization of Niyad™ submitted to the FDA in April Divestment of DSUVIA® to Alora Pharmaceuticals closed April 3, 2023 $13.4 million in cash as of March 31, 2023 Webcast and conference call to be held today at 4:30 p.m. EDT HAYWARD, Calif., May 10, 2023…


ADVERTISEMENT — Advertise With Biotech Networks